Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Common Stock Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2018			88,074,564
Beginning balance at Dec. 31, 2018	$ 665,866	$ 5,488	$ 1	$ 763,136	$ (897)	$ (94,204)	$ 5,488	$ (2,170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			113,810
Common stock issued for exercise of employee-based stock options	130			130
Stock-based compensation	1,503			1,503
Net loss	(46,682)					(46,682)
Unrealized gain (loss) on hedge transactions, net of tax	9							9
Foreign currency translation adjustment, net of tax	797							797
Ending Balance (in shares) at Dec. 31, 2019			88,188,374
Ending Balance at Dec. 31, 2019	627,111		$ 1	764,769	(897)	(135,398)		(1,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			143,760
Common stock issued for exercise of employee-based stock options	1,200			1,200
Issuance of common stock (in shares)			222,828
Issuance of common stock	2,050			2,050
Stock-based compensation	2,695			2,695
Net loss	(52,293)					(52,293)
Unrealized gain (loss) on hedge transactions, net of tax	638							638
Foreign currency translation adjustment, net of tax	1,783							1,783
Ending Balance (in shares) at Dec. 31, 2020			88,554,962
Ending Balance at Dec. 31, 2020	583,184		$ 1	770,714	(897)	(187,691)		1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			6,093
Common stock issued for exercise of employee-based stock options	56			56
Issuance of common stock (in shares)			276,022
Issuance of common stock	2,429			2,429
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)			4,760,000
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions	94,523		$ 48	94,475
Issuance of common stock in connection with forgiveness of promissory notes (in shares)			370,182
Issuance of common stock in connection with forgiveness of promissory notes	8,409			8,409
Capital contribution from Stockholder	15,576			15,576
Issuance of restricted shares (in shares)			1,779,716
Issuance of restricted shares, net of forfeitures and vesting	0		$ 19	(19)
Stock-based compensation	24,938			24,938
Net loss	(18,527)					(18,527)
Unrealized gain (loss) on hedge transactions, net of tax	(270)							(270)
Foreign currency translation adjustment, net of tax	(694)			0				(694)
Ending Balance (in shares) at Dec. 31, 2021			95,746,975
Ending Balance at Dec. 31, 2021	$ 709,624		$ 68	$ 916,578	$ (897)	$ (206,218)		$ 93